Showing results (1621-1630 of 6,192) with videos related to
Sort By:
Pageof 620
Clinical Nephrology|August 1, 1986
Peripheral lymphocyte subsets in human chronic pyelonephritisS Favaro, G Meneghel, G Rouben, et al.Clinical Nephrology|July 27, 2019
Temporal trends in fluid management with incremental hemodialysisIsai G Bowline, Greg B Russell, Benjamin Bagwell, et al.Clinical Nephrology|July 27, 2019
Co-occurrence of PLA2R-positive membranous nephropathy without crescents, and PR3-positive eosinophilic granulomatosis with polyangiitisYuexin Zhu, Qing Chang, Xiangyan Cao, et al.Clinical Nephrology|October 29, 2013
Cost-effectiveness of antiplatelet therapy to prolong primary patency of hemodialysis graftRobert Nee, Austin L Parker, Dustin J Little, et al.Clinical Nephrology|July 15, 2014
Oral phosphate binders in CKD - is calcium the (only) answer?David Goldsmith, Adrian CovicClinical Nephrology|July 15, 2014
Diffuse segmental and pure diffuse global proliferative glomerulonephritis: different patterns of class IV lupus nephritisShengchun Xu, Zhengzhao Liu, Huiping Chen, et al.Clinical Nephrology|December 21, 2013
Metabolic syndrome and chronic kidney disease as risk factors of osteoporosisJung-Ho Shin, Su Hyun Kim, Suk-Hee YuClinical Nephrology|August 28, 2014
Renal biopsy in patients over 75: 131 casesCristiana Rollino, Michela Ferro, Giulietta Beltrame, et al.Clinical Nephrology|June 28, 2016
Evaluation of urinary KIM-1, NGAL, and IL-18 levels in determining early renal injury in pediatric cases with hypercalciuria and/or renal calculiYasar Kandur, Sevim Gonen, Kibriya Fidan, et al.Clinical Nephrology|June 3, 2016
Fluconazole dosing predictions in critically-ill patients receiving prolonged intermittent renal replacement therapy: a Monte Carlo simulation approachKatherine N Gharibian, Bruce A MuellerPageof 620